Major indices finish lower amid GE earnings disappointment >>> READ MORE

Red-Hot Zulily Leads 12 IPOs This Week

Other notable deals include Extended Stay America and Houghton Mifflin Harcourt


Even though the Twitter (TWTR) IPO took much of the attention of investors last week, there were another 13 other deals that hit the market. And the activity for the upcoming week looks just as busy, with another 12 deals expected for this week.

Here’s a look at each of the companies expected to go public this week:


CardioDx develops medical diagnostics that use genomic technologies. The initial focus has been on coronary artery disease, arrhythmia and heart failure.

The machine, called Corus CAD, was launched in 2009 and has since provided more than 47,000 tests. About a year ago, it got approval for Medicare Part B coverage. (The program has roughly 48 million beneficiaries.)

For the first nine months of this year, sales jumped from $914,000 to $5.1 million. But the company still posted a loss of of $36.8 million in 2013.

CDX plans to issue 5 million shares at a price range of $14 to $16 and the lead underwriters include BofA Merrill Lynch (BAC) and Jefferies.


Celladon is a clinical-stage biotech operator that uses SERCA enzymes that deal with intra-cellular calcium. The lead candidate is Mydicar, which treats heart failure, but the company has plans to develop drugs  for other major problems like diabetes and neurodegenerative diseases.

The company plans to issue 5 million shares at a price range of $14 to $16. The lead underwriters include J.P. Morgan (JPM) and Barclays (BCS).


Chegg manages a platform that allows students to rent textbooks.

There are about 180,000 unique titles available and more than 100,000 eTextbook titles. The mobile app also has 1.2 million downloads. The company also offers other services, such as resources to help choose a college and even get help with homework assignments.

From 2010 to 2012, revenues climbed from $148.9 million to $213.3 million. However, the company posted a net loss of $49 million, last year.

CHGG plans to issue 15 million shares at a price range of $9.50 to $11.50. The lead underwriters include J.P. Morgan and BofA Merrill Lynch.

Dynagas LNG Partners

Dynagas LNG Partners is a master limited partnership that owns and operates a fleet of LNG carriers. The company has multi-year contracts with companies like BG Group and Gazprom

The current fleet consists of three vessels, which are built to withstand extreme environments — capable of withstanding temperatures of negative 30 degrees Celsius.

For the first half of this year, revenues increased by 14% to $42.4 million and earnings climbed from $14.4 million to $22.7 million.

DLNG plans to offer 12.5 million shares at a price range of $19 to $21. The lead underwriters include Credit Suisse (CS), BofA Merrill Lynch, Morgan Stanley (MS), Barclays and Deutsche Bank (DB).

Eros International

Eros International was supposed to go public last week, actually. The company is a top producer, owner and distributor of Indian-language films. The library includes more than 2,000 titles, as well as 700 additional films for which it holds digital rights only.

During fiscal years 2011 to 2013, revenues increased from $164.6 million to $215.4 million. However, net income fell from $47.6 million to $33.7 million.

Eros plans to issue 12.5 million shares at a range of $15.00 to $17.00. The lead underwriters include Deutsche Bank, BofA Merrill Lynch, UBS Investment Bank and Jefferies & Co.

Extended Stay America

During the financial crisis in 2009, Extended Stay America filed for bankruptcy. But Blackstone (BX) joined forces with Centerbridge and Paulson & Co. to buy the company for about $3.9 billion.

Since then, STAY has undergone a successful restructuring. The company is now the largest owner and operator of company-branded hotels in North America, with a chain of 682 hotel properties. And it’s a highly profitable business — last year, the company generated $434.3 million in adjusted EBITDA on revenues of $1 billion.

STAY plans to issue 28.3 million shares at a price range of $18 to $21. The lead underwriters include Deutsche Bank, Goldman Sachs (GS) and J.P. Morgan.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC